47
Participants
Start Date
June 30, 2005
Primary Completion Date
December 31, 2013
Study Completion Date
December 31, 2013
CD34+ selection with CliniMACS device
CD34+ cell selection will be performed according to procedures given in the CliniMACS Users Operating Manual and institutional Standard Operating Procedures (SOPs) in place and validated at the study sites. CliniMACS (Miltenyi device) to target CD34+ \>5 x 10\*6/kg and CD3+ \< 1 x 10\*5/kg
Memorial Sloan-Kettering Cancer Center, New York
University of Pennsylvania Cancer Center, Philadelphia
Ohio State/Arthur G. James Cancer Hospital, Columbus
University Hospitals of Cleveland/Case Western, Cleveland
Medical College of Wisconsin, Milwaukee
City of Hope National Medical Center, Duarte
University of California, San Francisco, San Francisco
Dana Farber Cancer Institute/Brigham & Women's Hospital, Boston
Blood and Marrow Transplant Clinical Trials Network
NETWORK
National Cancer Institute (NCI)
NIH
National Heart, Lung, and Blood Institute (NHLBI)
NIH